These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6372445)

  • 1. The absence of effect of azathioprine on prednisolone pharmacokinetics following maintenance prednisone doses in kidney transplant patients.
    Gambertoglio JG; Holford HG; Lizak PS; Birnbaum JL; Salvatierra O; Amend WJ
    Am J Kidney Dis; 1984 May; 3(6):425-9. PubMed ID: 6372445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone.
    Frey FJ; Lozada F; Guentert T; Frey BM
    Eur J Clin Pharmacol; 1981 Feb; 19(3):209-12. PubMed ID: 7215419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone and prednisolone bioavailability in renal transplant patients.
    Gambertoglio JG; Frey FJ; Holford NH; Birnbaum JL; Lizak PS; Vincenti F; Feduska NJ; Salvatierra O; Amend WJ
    Kidney Int; 1982 Apr; 21(4):621-6. PubMed ID: 7047863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that cyclosporine does not affect the metabolism of prednisolone after renal transplantation.
    Frey FJ; Schnetzer A; Horber FF; Frey BM
    Transplantation; 1987 Apr; 43(4):494-8. PubMed ID: 3554641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of total and unbound prednisolone in renal transplant patients receiving anticonvulsants.
    Gambertoglio JG; Holford NH; Kapusnik JE; Nishikawa R; Saltiel M; Stanik-Lizak P; Birnbaum JL; Hau T; Amend WJ
    Kidney Int; 1984 Jan; 25(1):119-23. PubMed ID: 6374250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM; Walker C; Frey FJ; de Weck AL
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
    Frey BM; Seeberger M; Frey FJ
    Transplantation; 1985 Mar; 39(3):270-4. PubMed ID: 3883592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose dependent pharmacokinetics of prednisone and prednisolone in man.
    Rose JQ; Yurchak AM; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):389-417. PubMed ID: 7310640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.
    Bergmann TK; Barraclough KA; Lee KJ; Staatz CE
    Clin Pharmacokinet; 2012 Nov; 51(11):711-41. PubMed ID: 23018468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of sucralfate on prednisone bioavailability.
    Gambertoglio JG; Romac DR; Yong CL; Birnbaum J; Lizak P; Amend WJ
    Am J Gastroenterol; 1987 Jan; 82(1):42-5. PubMed ID: 3799579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive properties of sera and urine dialysates from kidney-graft recipients treated with azathioprine, prednisolone, and niridazole.
    Jones BM; Bird M; Massey P; Millar D; Miller JJ; Reeves S; Salaman JR
    Br Med J; 1977 Sep; 2(6090):792-5. PubMed ID: 334335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus.
    Ionita IA; Ogasawara K; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2014 Aug; 36(4):448-55. PubMed ID: 24452065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.
    Boudinot FD; Jusko WJ
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):453-67. PubMed ID: 3806371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous and exogenous glucocorticoids in cushingoid patients.
    Benet LZ; Frey FJ; Amend WJ; Lozada F; Frey BM
    Drug Intell Clin Pharm; 1982 Nov; 16(11):863-8. PubMed ID: 6756849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW; Axelsen E
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients.
    Bergrem H; Jervell J; Flatmark A
    Kidney Int; 1985 Feb; 27(2):459-64. PubMed ID: 3887001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients.
    Gambertoglio JG; Vincenti F; Feduska NJ; Birnbaum J; Salvatierra O; Amend WJ
    J Clin Endocrinol Metab; 1980 Sep; 51(3):561-5. PubMed ID: 6997330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring prednisone and prednisolone.
    Jusko WJ; Rose JQ
    Ther Drug Monit; 1980; 2(2):169-76. PubMed ID: 6762710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics.
    Rose JQ; Yurchak AM; Meikle AW; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):1-14. PubMed ID: 7229914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic growth after kidney transplantation. Beneficial effect of cyclosporine in comparison with conventional immunosuppression.
    Offner G; Hoyer PF; Jüppner H; Krohn HP; Brodehl J
    Am J Dis Child; 1987 May; 141(5):541-6. PubMed ID: 3554980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.